Elevance Health
1,510 hedge funds and large institutions have $63.3B invested in Elevance Health in 2025 Q3 according to their latest regulatory filings, with 165 funds opening new positions, 531 increasing their positions, 608 reducing their positions, and 223 closing their positions.
14% more call options, than puts
Call options by funds: $953M | Put options by funds: $837M
0% more funds holding in top 10
Funds holding in top 10: 32 → 32 (0)
3.76% less ownership
Funds ownership: 90.78% → 87.02% (-3.8%)
5% less funds holding
Funds holding: 1,589 → 1,510 (-79)
13% less repeat investments, than reductions
Existing positions increased: 531 | Existing positions reduced: 608
21% less capital invested
Capital invested by funds: $79.7B → $63.3B (-$16.4B)
26% less first-time investments, than exits
New positions opened: 165 | Existing positions closed: 223
Top Buyers
| 1 |
Harris Associates
Chicago,
Illinois
|
+$281M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$280M |
| 3 |
First Eagle Investment Management
New York
|
+$248M |
| 4 |
BWA
Brave Warrior Advisors
New York
|
+$225M |
| 5 |
BG
Baupost Group
Boston,
Massachusetts
|
+$219M |
Top Sellers
ELV Hedge Fund Activity: Q3 2025 in Review
1,510 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2025, worth a combined $63.3B — down 21% from $79.7B a quarter earlier.
Sellers outnumbered buyers: 223 funds closed out of ELV and 165 opened new positions — a net loss of 58 holders — while 608 trimmed existing stakes and 531 added.
The largest buyer was Harris Associates, adding an estimated $281M. The largest seller was Capital International Investors, cutting an estimated $1.1B.
- 1,510 institutional investors held Elevance Health (ELV) as of Q3 2025, down from 1,589 in Q2 2025.
- Funds reported $63.3B of Elevance Health stock for Q3 2025, down 21% quarter-over-quarter.
- 165 funds opened new Elevance Health positions in Q3 2025 and 223 closed out, a net change of -58 holders.
- The largest Elevance Health buyer in Q3 2025 was Harris Associates, an estimated $281M added.
- The largest Elevance Health seller in Q3 2025 was Capital International Investors, an estimated $1.1B sold.
Based on aggregated 13F filings for Q3 2025.